Ureteral Stents Market Research Report - Global Forecast till 2025

Global Ureteral Stents Market Research Report: Information by Type (Double Pigtail Ureteral Stent and others), Material (Metallic Stents, Polymers Stents and others), Treatment (Kidney Stones, Kidney Transplant and others), End-User (Hospitals, Nephrological Centers and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025

ID: MRFR/MED/0880-HCR | February 2021 | Region: Global | 95 pages

Market Scenario


Ureteral Stents Market is expected to register 6.6% CAGR during the forecast period of 2019 to 2025, with a market value of USD 302.5 Million in 2018.


A ureteral stent is a thin tube inserted into the ureter to prevent or treat an obstruction of the urine flow from the kidney. The length of the stents used in adult patients varies between 24 and 30 cm.


The global ureteral stents market is driven by factors such as the rising prevalence of kidney diseases and the increasing number of kidney transplants.


Additionally, the technological advancements in ureteral stents and the rising adoption of minimally invasive surgeries are anticipated to fuel the market growth.


For instance, as per the Global Observatory on Donation and Transplantation, in 2016, 89,823 kidney transplants were done globally. Thus, the rising number of kidney transplants fueling the growth of the market.


Moreover, major companies in the market are involved in strategic acquisitions, collaborations, mergers, and new launches to sustain their position in the market.


 For instance, in February 2017, Cook Medical launched Universa, a soft ureteral stent set, in its streamline percutaneous urinary drainage product line. This helped strengthen its ureteral stents product portfolio.


Segmentation


The global ureteral stents market has been segmented based on type, material, treatment, end users, and region.


The global market, based on type, has been bifurcated into double pigtail ureteral stent and others.


The double pigtail ureteral stent segment is expected to hold a significant share of the market due growing use of double pigtail ureteral stents as it provides a safe and effective method of ensuring urinary drainage.


Based on material, the global market is segmented into metallic stents, polymers stents, and others. The polymers stents segment is expected to hold a major share of the market due to growing use of bioabsorbable stents and technological improvement in ureteral stents.


The market, based on treatment, has been divided into kidney stones, kidney transplants, and others.


The kidney stones treatment is expected to hold a major share in the market due to the increasing prevalence of kidney stones. For example, according to Urology Annals, in 2018, worldwide, prevalence of kidney stones is 7% in adults, which will increase with recurrence rate of 30% within ten years. The incidence of kidney stones is growing globally with an estimated prevalence ranging up to 15%. During their lifetime, approximately 7% of women and 13% of men will develop a kidney stone.


Based on end user, the market is segmented into hospitals, nephrological centers, and ambulatory surgical centers. The hospitals segment is expected to hold a major share in the market due availability of facilities for kidney transplant procedures and availability of expertise in the hospital.


The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The ureteral stents market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European ureteral stents market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


 The ureteral stents market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The ureteral stents market in the Middle East & Africa has been divided into the Middle East and Africa.


Key Players


The Key Players operating in the Global Ureteral Stents Market are Boston Scientific (US), Cook Medical (US), C.R. Bard (US), B. BRAUN (Germany), Olympus (Japan), Coloplast (Denmark), Allium Medical (Israel), Teleflex Incorporated (US), Biomerics (Italy), Medline industries inc. (US), Merit Medical Systems, Inc. (US), and BrightWater Medical (US).


Regional Market Summary


Global Ureteral Stents Market Share by Region, 2018 (%)
 Ureteral Stents Market


Source: World Health Organization (WHO)


The market in the Americas is expected to dominate the ureteral stents market due to the growing early product commercialization in the region, growing use of ureteral stents and the involvement of key companies are driving the growth of this market. The increasing incidence of kidney diseases in the US and Canada is expected to drive the market growth.


For instance, as per the statement of the National Center for Biotechnology Information, in the US, kidney stone affects 1 in 11 individuals, and it is estimated that 600,000 Americans suffer from kidney stones each year.


The market in the Asia-Pacific is expected to hold the second-largest share of the ureteral stents market due to the growing prevalence of kidney diseases, increasing geriatric population, and the increasing awareness about advanced medical devices in the region.


For example, as per the statement of the National Center for Biotechnology Information, in India about 12% of the population is expected to have urinary stones, of which 50% may end up with loss of kidney functions.


The market in Europe is projected to have a steady growth rate during the forecast period owing to the increasing preference for minimally invasive procedures and improved insurance and reimbursement policies.


The market in the Middle East & Africa is projected to account for the least share of the market due to low per capita disposable income in the region.


Global Ureteral Stents Market, by Type



  • Double Pigtail Ureteral Stent

  • Others


Global Ureteral Stents Market, by Material



  • Metallic Stents

  • Polymers Stents

  • Others


Global Ureteral Stents Market, by Treatment



  • Kidney Stones

  • Kidney Transplant

  • Others


Global Ureteral Stents Market, by End User



  • Hospitals

  • Nephrological Centers

  • Ambulatory Surgical Centers


Global Ureteral Stents Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Research and development (R&D) companies

  • Medical device companies

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists



Frequently Asked Questions (FAQ) :


The valuation of the global ureteral stents market had reached USD 302.5 MN in 2018.

global ureteral stents market is projected to grow at 6.6% CAGR during the assessment period (2019-2025).

Technological advances in ureteral stents and rising adoption of minimally invasive surgeries are the major tailwinds pushing the growth of the global ureteral stents market.

North America holds the largest share in the global ureteral stents market, followed by Europe and the Asia Pacific, respectively.

Cook Medical (US), Boston Scientific (US), C.R. Bard (US), Olympus (Japan), B. BRAUN (Germany), Coloplast (Denmark), Teleflex Incorporated (US), Allium Medical (Israel), Biomerics (Italy), Merit Medical Systems, Inc. (US), Medline industries Inc. (US), and BrightWater Medical (US), are some of the major players operating in the ureteral stents market.

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis


6. GLOBAL URETERAL STENTS MARKET, BY TYPE

6.1. Overview

6.2. Double Pigtail Ureteral Stent

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.3. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025
7. GLOBAL URETERAL STENTS MARKET, BY MATERIAL

7.1. Overview

7.2. Metallic Stents

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.3. Polymers Stents

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.4. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025
8. GLOBAL URETERAL STENTS MARKET, BY TREATMENT

8.1. Overview

8.2. Kidney Stones

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.3. Kidney Transplant

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025
8.4. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025
9. GLOBAL URETERAL STENTS MARKET, BY END USER

9.1. Overview

9.2. Hospitals

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

9.3. Nephrology Centers

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

9.4. Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025
10. GLOBAL URETERAL STENTS MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Ureteral Stents Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of the Number of Developments in the Global Ureteral Stents Market

11.7. Key Developments and Growth Strategies

11.7.1. Product Launch/Service Deployment

11.7.2. Mergers and Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix & Market Ratio

11.8.1. Sales & Operating Income 2018

11.8.2. Major Players R&D Expenditure 2018

11.9. Major Players Capital Market Ratio

12. COMPANY PROFILES

12.1. Boston Scientific

12.1.1. Company Overview

12.1.2. Product Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Cook Medical

12.2.1. Company Overview

12.2.2. Product Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. C.R. Bard

12.3.1. Company Overview

12.3.2. Product Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. B. BRAUN

12.4.1. Company Overview

12.4.2. Product Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Olympus

12.5.1. Company Overview

12.5.2. Product Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Coloplast

12.6.1. Company Overview

12.6.2. Product Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Allium Medical

12.7.1. Company Overview

12.7.2. Product Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Teleflex Incorporated

12.8.1. Company Overview

12.8.2. Product Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Biomerics

12.9.1. Company Overview

12.9.2. Product Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Medline industries, Inc.

12.10.1. Company Overview

12.10.2. Product Overview

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Merit Medical Systems, Inc.

12.11.1. Company Overview

12.11.2. Product Overview

12.11.3. Financial Overview

12.11.4. Key Developments

12.11.5. SWOT Analysis

12.11.6. Key Strategies

12.12. BrightWater Medical

12.12.1. Company Overview

12.12.2. Product Overview

12.12.3. Financial Overview

12.12.4. Key Developments

12.12.5. SWOT Analysis

12.12.6. Key Strategies

12.13. Others
13. APPENDIX

13.1. References

13.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL URETERAL STENTS MARKET SYNOPSIS, 2019–2025

TABLE 2 GLOBAL URETERAL STENTS MARKET ESTIMATES & FORECAST, 2019–2025 (USD MILLION)

TABLE 3 GLOBAL URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 4 GLOBAL URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 5 GLOBAL URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 6 GLOBAL URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 7 GLOBAL URETERAL STENTS MARKET, BY REGION, 2019–2025 (USD MILLION)

TABLE 8 NORTH AMERICA: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 9 NORTH AMERICA: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 10 NORTH AMERICA: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 11 NORTH AMERICA: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 12 US: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 13 US: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 14 US: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 15 US: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 16 CANADA: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 17 CANADA: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 18 CANADA: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 19 CANADA: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 20 LATIN AMERICA: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 21 LATIN AMERICA: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 22 LATIN AMERICA: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 23 LATIN AMERICA: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 24 EUROPE: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 25 EUROPE: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 26 EUROPE: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 27 EUROPE: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)
TABLE 28 WESTERN EUROPE: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 29 WESTERN EUROPE: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 30 WESTERN EUROPE: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 31 WESTERN EUROPE: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 32 EASTERN EUROPE: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 33 EASTERN EUROPE: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 34 EASTERN EUROPE: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 35 EASTERN EUROPE: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 36 ASIA-PACIFIC: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 37 ASIA-PACIFIC: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 38 ASIA-PACIFIC: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 39 ASIA-PACIFIC: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: URETERAL STENTS MARKET, BY TYPE, 2019–2025 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: URETERAL STENTS MARKET, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: URETERAL STENTS MARKET, BY TREATMENT, 2019–2025 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: URETERAL STENTS MARKET, BY END USER, 2019–2025 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL URETERAL STENTS MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL URETERAL STENTS MARKET

FIGURE 4 GLOBAL URETERAL STENTS MARKET SHARE, BY TYPE, 2018 (%)

FIGURE 5 GLOBAL URETERAL STENTS MARKET SHARE, BY MATERIAL, 2018 (%)

FIGURE 6 GLOBAL URETERAL STENTS MARKET SHARE, BY TREATMENT, 2018 (%)

FIGURE 7 GLOBAL URETERAL STENTS MARKET SHARE, BY END USER, 2018 (%)

FIGURE 8 GLOBAL URETERAL STENTS MARKET SHARE, BY REGION, 2018 (%)

FIGURE 9 AMERICAS: URETERAL STENTS MARKET SHARE BY REGION, 2018 (%)

FIGURE 10 NORTH AMERICA: URETERAL STENTS MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 11 EUROPE: URETERAL STENTS MARKET SHARE, BY REGION, 2018 (%)

FIGURE 12 WESTERN EUROPE: URETERAL STENTS MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 13 ASIA-PACIFIC: URETERAL STENTS MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 14 MIDDLE EAST & AFRICA: URETERAL STENTS MARKET SHARE, BY COUNTRY, 2018 (%)

FIGURE 15 GLOBAL URETERAL STENTS MARKET: COMPANY SHARE ANALYSIS, 2018 (%)

FIGURE 16 BOSTON SCIENTIFIC: KEY FINANCIALS

FIGURE 17 BOSTON SCIENTIFIC: SEGMENTAL REVENUE

FIGURE 18 BOSTON SCIENTIFIC: REGIONAL REVENUE

FIGURE 19 COOK MEDICAL: KEY FINANCIALS

FIGURE 20 COOK MEDICAL: SEGMENTAL REVENUE

FIGURE 21 COOK MEDICAL: REGIONAL REVENUE

FIGURE 22 C.R. BARD: KEY FINANCIALS

FIGURE 23 C.R. BARD: SEGMENTAL REVENUE

FIGURE 24 C.R. BARD: REGIONAL REVENUE

FIGURE 25 B. BRAUN: KEY FINANCIALS

FIGURE 26 B. BRAUN: SEGMENTAL REVENUE

FIGURE 27 B. BRAUN: REGIONAL REVENUE

FIGURE 28 OLYMPUS: KEY FINANCIALS

FIGURE 29 OLYMPUS: SEGMENTAL REVENUE

FIGURE 30 OLYMPUS: REGIONAL REVENUE

FIGURE 31 COLOPLAST: KEY FINANCIALS

FIGURE 32 COLOPLAST: SEGMENTAL REVENUE

FIGURE 33 COLOPLAST: REGIONAL REVENUE

FIGURE 34 ALLIUM MEDICAL: KEY FINANCIALS

FIGURE 35 ALLIUM MEDICAL: SEGMENTAL REVENUE

FIGURE 36 ALLIUM MEDICAL: REGIONAL REVENUE

FIGURE 37 TELEFLEX INCORPORATED: KEY FINANCIALS

FIGURE 38 TELEFLEX INCORPORATED: SEGMENTAL REVENUE

FIGURE 39 TELEFLEX INCORPORATED: REGIONAL REVENUE

FIGURE 40 BIOMERICS: KEY FINANCIALS

FIGURE 41 BIOMERICS: SEGMENTAL REVENUE

FIGURE 42 BIOMERICS: REGIONAL REVENUE

FIGURE 43 MEDLINE INDUSTRIES INC: KEY FINANCIALS

FIGURE 44 MEDLINE INDUSTRIES INC: SEGMENTAL REVENUE

FIGURE 45 MEDLINE INDUSTRIES INC.: REGIONAL REVENUE

FIGURE 46 MERIT MEDICAL SYSTEMS, INC.: KEY FINANCIALS

FIGURE 47 MERIT MEDICAL SYSTEMS, INC.: SEGMENTAL REVENUE

FIGURE 48 MERIT MEDICAL SYSTEMS, INC.: REGIONAL REVENUE

FIGURE 49 BRIGHTWATER MEDICAL: KEY FINANCIALS

FIGURE 50 BRIGHTWATER MEDICAL: SEGMENTAL REVENUE

FIGURE 51 BRIGHTWATER MEDICAL: REGIONAL REVENUE